Department of Pharmacology

May 25, 2017

Vanderbilt, Ono Pharmaceutical extend drug discovery agreement

Vanderbilt University Medical Center (VUMC), Vanderbilt University and Japan-based Ono Pharmaceutical Co. Ltd. have expanded a drug discovery agreement initiated in 2015 that will now run through 2019.

By VUMC News and Communications
May 11, 2017

Discovery Lecturer Kandel tackles age-related memory loss

Eric Kandel, M.D., who was awarded the Nobel Prize in 2000 for discovering molecular mechanisms of memory storage, told the crowd at last week’s Flexner Discovery Lecture that he has recently become interested in memory in the aging brain.

By Leigh MacMillan
April 27, 2017

Barnett named co-chair of VUSM Admissions Committee

Joey Barnett, Ph.D., has been named co-chair of the Vanderbilt University School of Medicine Admissions Committee, effective July 1.

By Kathy Whitney
April 27, 2017

Nobel laureate and memory expert Kandel set for next Discovery Lecture

Nobel laureate Eric R. Kandel, M.D., renowned for his studies of learning and memory, will give the next Flexner Discovery Lecture on Thursday, May 4.

By Leigh MacMillan
April 20, 2017

Graduate student’s research lauded by P.E.O. Sisterhood

Nicole Perry, a graduate student in Pharmacology at Vanderbilt University School of Medicine, is one of 100 doctoral students in the United States and Canada selected to receive a $15,000 P.E.O. Scholar Award this year from the P.E.O. Sisterhood, a philanthropic educational organization based in Des Moines, Iowa.

By Bill Snyder
March 23, 2017

Emerging Scholar

Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week.

By VUMC News and Communications
March 9, 2017

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.
By Bill Snyder
January 12, 2017

Lindsley’s drug discovery efforts land ASPET Award

Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
December 16, 2016

Research that ruled in 2016: Readers’ favorite stories

Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
By VUMC News and Communications
December 1, 2016

Investigators explore new way to control mosquitoes

In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth.
By Paul Govern
November 23, 2016

Reducing antidepressants’ side effects

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.
By VUMC News and Communications
November 3, 2016

Brown named interim director of Institute of Chemical Biology

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
By Bill Snyder
October 20, 2016

Study finds natural compound extends lifespan of worms

A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.
By Leigh MacMillan
1 … 6 7 8 9 10 … 14